• You are here:  
  • Home
  • Press Release

Research Finds Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® Effective for Non-Alcoholic Fatty Liver Disease

Details
Press Release
939
Sabinsa cosmetics

Sabinsa’s Curcumin C3 Complex®, the #1 researched curcumin ingredient on the market, was used in a new published study on Non-Alcoholic Fatty Liver Disease (NAFLD), the most common chronic liver condition for which no approved pharmaceutical treatments exist.

Sami-Sabinsa Honored with Multiple “Best of” Awards in New Delhi and Singapore

Details
Press Release
878
Sabinsa cosmetics

The Sami-Sabinsa Group was honored with numerous awards in recent weeks, being named “best of” in categories ranging from herbal research to beverage taste. The Sami-Sabinsa Group’s founder, Chairman, and Managing Director, Dr. Muhammed Majeed, was commended as well.

Sabinsa Founder Dr. Muhammed Majeed Publishes Book on Reductive Metabolites of Curcuminoids

Details
Press Release
915
Sabinsa cosmetics

Sabinsa’s founder, Chairman, and Managing Director Dr. Muhammed Majeed announced the publication of a new book; this latest is entitled “Reductive Metabolites of Curcuminoids.” Over the last two decades curcuminoids have been the most intensively studied herbal constituents, and Sabinsa has been at the forefront of much of the research.

Sabinsa to Feature Tinofolin® Nootropic, Livinol™ for Liver Health & Weight Control, and Starmeric™ Turmeric-Derived Prebiotic at Supplyside West

Details
Press Release
1012
Sabinsa cosmetics

Sabinsa is the official Curcumin Sponsor of SupplySide West, to be held October 17 - 18, 2019, at the Mandalay Bay Convention Center, Las Vegas, NV. The company will highlight several condition-specific branded ingredient products from its extensive portfolio in booth #4131.

Pilot Study Published Examining Curcumin C3 Complex® and BioPerine® With Taurine as Treatment for Hepatocellular Carcinoma

Details
Press Release
878
Sabinsa cosmetics

The body of research supporting efficacy of Sabinsa’s branded ingredients continues to grow with a recent clinical paper reporting on the use of the company’s Curcumin C3 Complex® and BioPerine®, and taurine on hepatocellular carcinoma (HCC) patients: A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: a pilot study published in the Journal of Gastrointestional Oncology.

Study Shows Inhibitory Effect of Curcumin C3 Complex® and BioPerine® Combination on Malignant Mesothelioma Cells

Details
Press Release
865
Sabinsa cosmetics

Sabinsa’s Curcumin C3 Complex® in combination with BioPerine® (CBP) has an inhibitory effect on malignant mesothelioma cells, according to an in vitro and in vivo study published in Journal of Experimental and Clinical Cancer Research.

Sabinsa Opens Sales Office in Poland to Serve Eastern Europe

Details
Press Release
894
Sabinsa cosmetics

Sabinsa continues its global expansion with the opening of a warehousing, sales and distribution office in Poland and bringing on staff to serve customers in the growing East European, Eastern Block as well as CIS countries.

Sabinsa’s Four Indian Manufacturing Sites Achieve FSSC 22000 Certification

Details
Press Release
992
Sabinsa cosmetics

Sabinsa’s four Sami Labs manufacturing sites in India were recently audited by the licensed Certification Body, Bureau Veritas Certification Holding SAS – UK branch, and achieved Foundation Food Safety System Certification 22000 (FSSC 22000). FSSC 22000 replaces the previous ISO 22000: 2005 - FSMS (Food Safety Management System) achieved by these Sami facilities till 2018.

New Research Expands upon Use of Sabinsa’s Curcumin C3 Complex® as an Adjunct to Chemotherapy

Details
Press Release
1037
Sabinsa cosmetics

Sabinsa’s Curcumin C3 Complex® has been studied as an adjuvant therapy with several cancer drugs in the past, and the body of science continues to grow with the recent publication of more positive research.

Sabinsa’s Curcumin C3 Reduct® Self-Affirmed Gras

Details
Press Release
1290
c3reduct

Patented Turmeric Extract Deemed Safe for Use in Foods and Beverages

After a comprehensive review of safety and toxicology data by an independent panel of scientists of international repute convened by Soni & Associates Inc., Sabinsa’s patented color-free Curcumin C3 Reduct® tetrahydrocurcuminoids, a metabolite of curcumin, has been found to meet criteria as Generally Recognized As Safe (GRAS) as per FDA’s scientific procedures.